
A drug commonly used to treat the autoimmune disease rheumatoid arthritis (RA) could also slow the progression of type 1 diabetes, an early clinical trial suggests.
Similar to RA, type 1 diabetes is an autoimmune condition — in RA, the body's immune cells attack the joints, while in diabetes, they destroy insulin-producing beta cells in the pancreas. The resulting insulin deficiency means cells can't remove glucose from the bloodstream, causing blood sugar to skyrocket. Treating type 1 diabetes requires daily insulin injections.